Kaerus Bioscience
PrivateCompany Overview
Kaerus Bioscience is a biotechnology company that develops targeted therapeutics for rare neurodevelopmental disorders such as Fragile X syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kaerus Bioscience Comparables
Compare Kaerus Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autifony Therapeutics Limited | 86% | |
| Spinogenix, Inc. | 84% | |
| Confluence Pharmaceuticals | 84% |
Kaerus Bioscience Funding Rounds
Historical fundraising activity
Kaerus Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kaerus Bioscience's valuation, stock price, and market status.
Is Kaerus Bioscience a public or private company?
Kaerus Bioscience is a private company.
What is the current stock price of Kaerus Bioscience?
Kaerus Bioscience is a private company with no public stock price. Caplight tracks Kaerus Bioscience's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Kaerus Bioscience worth (valuation)?
Valuation information for Kaerus Bioscience is not publicly available.
Can I buy Kaerus Bioscience stock?
Kaerus Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kaerus Bioscience's last funding round?
Funding round information for Kaerus Bioscience is not publicly available.
Who are the main investors in Kaerus Bioscience?
Investor information for Kaerus Bioscience is not publicly disclosed.
Will Kaerus Bioscience IPO soon?
No public IPO plans have been announced for Kaerus Bioscience.
How can I track Kaerus Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kaerus Bioscience's secondary market activity and sign up for updates.